Althea Group Holdings Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AGH.AX research report →
Price Chart
About the company
Althea Group Holdings Limited is engaged in the cultivation, distribution, and sale of both therapeutic and recreational cannabis products across a global footprint, including Australia, the United Kingdom, Germany, and Canada. Beyond its product offerings, the company provides essential support services, such as educational programs, access facilitation, and treatment management, to empower eligible patients and healthcare professionals in navigating the landscape of medicinal cannabis. Althea also actively formulates and manufactures a diverse array of recreational cannabis items, ranging from beverages and edibles to concentrates and topicals.
- CEO
- Barry Katzman
- IPO
- 2018
- HQ
- Melbourne, VIC, AU
Get TickerSpark's AI analysis on AGH.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
Latest fiscal year · YoY change
- Revenue
- $15.49M-47.3%
- Gross Profit
- $7.47M-57.2%
- Op Income
- $-2,401,000
- Net Income
- $-8,346,999+74.0%
- EPS
- $-0.01+89.8%
- OCF Growth
- -61.4%
- FCF Growth
- -65.9%
- 52W High
- $0.04
- 52W Low
- $0.02
- 50D MA
- $0.02
- 200D MA
- $0.02
- Beta
- 1.52
- RSI (14)
- 43
- Avg Volume
- 1.37M
No earnings-call transcripts are available for AGH.AX yet.
- Free Float
- 68.0%
- Shares Outstanding
- 845.47M
- Float Shares
- 574.64M
Our AGH.AX coverage
Recent articles, reports, and earnings notes.
No research on AGH.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AGH.AX report →